Skip to main content
padlock icon - secure page this page is secure

Open Access Contemporary Management of Patients with Stable Ischemic Heart Disease

Download Article:
 Download
(HTML 66.1 kb)
 
or
 Download
(PDF 137.8 kb)
 

This article is Open Access under the terms of the Creative Commons CC BY-NC licence.

The overall goals of therapy for patients with stable ischemic heart disease are to minimize the likelihood of death while maximizing health and function. Initial risk assessment with noninvasive testing is indicated to determine whether invasive evaluation is needed in addition to medical therapy. All patients with stable ischemic heart disease need optimal medical therapy, which includes risk factor management with lifestyle modifications and pharmacologic therapy. First-line pharmacologic therapy is focused on preventing myocardial infarction and death with antiplatelet agents, lipid-lowering therapy, and antihypertensive therapies. In addition, antianginal therapy and anti-ischemic therapy are indicated to alleviate symptoms, reduce ischemia, and improve quality of life. The commonly used antianginal agents include nitrates, beta-blockers, calcium channel blockers, and ranolazine. When medical therapy is not adequate to relieve angina, revascularization with percutaneous coronary intervention or coronary artery bypass grafting is indicated. We review the indications and evidence for antianginal agents and other therapies for angina.
No References for this article.
No Supplementary Data.
No Article Media
No Metrics

Keywords: coronary artery disease; optimal medical therapy; stable ischemic heart disease

Document Type: Research Article

Publication date: 01 January 2019

More about this publication?
  • Cardiovascular Innovations and Applications (CVIA) publishes focused articles and original clinical research that explore novel developments in cardiovascular disease, effective control and rehabilitation in cardiovascular disease, and promote cardiovascular innovations and applications for the betterment of public health globally. The journal publishes basic research that has clinical applicability in order to promote timely communication of the latest insights relating to coronary artery disease, heart failure, hypertension, cardiac arrhythmia, prevention of cardiovascular disease with a heavy emphasis on risk factor modification. Cardiovascular Innovations and Applications is the official journal of the Great Wall International Congress of Cardiology (GW-ICC). It aims to continue the work of the GW-ICC by providing a global scientific communication platform for cardiologists that bridges East and West.

  • Editorial Board
  • Information for Authors
  • Submit a Paper
  • Subscribe to this Title
  • Membership Information
  • Information for Advertisers
  • Terms & Conditions
  • Ingenta Connect is not responsible for the content or availability of external websites
  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content
Cookie Policy
X
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more